Oncolytics Biotech
Officials at Oncolytics Biotech announce latest news and research developments
Published in Lab Business Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Oncolytics Biotech.
Report 1: Oncolytics Biotech Inc. (ONC, ONCY) announced the appointment of Mary Ann Dillahunty as vice president, Intellectual Property.
Report 2: Oncolytics Biotech Inc. (ONC, ONCY) has completed patient enrollment in its Phase I U.S. clinical trial investigating the systemic delivery of Reolysin to treat patients with advanced cancers.
Eighteen patients were treated in the Phase I trial with Reolysin at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-04-29)
More Articles from Lab Business Week
- Biomedical Engineering
New biomedical engineering research has been reported by scientists at Abbott Laboratories - Breast Cancer Genetics
Studies from Chester Beatty Laboratories yield new data on breast cancer genetics - Carrington Laboratories, Inc.
Carrington Announces Information in Compliance with NASDAQ Rules - Charles River Laboratories
Charles River Laboratories Schedules First-Quarter 2007 Earnings Release and Conference Call - Drug Development
Pharmatek Opens New Facility - Epilepsy
Study results from Abbott Laboratories broaden understanding of epilepsy - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
